Generic name:pancrelipase
Drug class:Digestive enzymes
Approval date: March 1, 2012
Company: Aptalis Pharma US, Inc.
Treatment for: Exocrine Pancreatic Insufficiency due to Chronic Pancreatitis or Pancreatectomy
Medically reviewed by Drugs.com. Last updated on Aug 24, 2021.
FDA Approves Viokace
The U.S. Food and Drug Administration (FDA) has approved Viokace (pancrelipase) tablets for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy.
Viokace Medication Guide
Read this Medication Guide before you start taking Viokace and each time you get a refill. There may be new information. This information does not take the place of talking with your doctor about your medical condition or treatment.
Warnings
Viokace may increase your chance of having a rare bowel disorder called fibrosing colonopathy. This condition is serious and may require surgery. The risk of having this condition may be reduced by following the dosing instructions that your doctor gave you.
Call your doctor right away if you have any unusual or severe:
- stomach area (abdominal) pain
- bloating
- trouble passing stool (having bowel movements)
- nausea, vomiting, or diarrhea
Take Viokace exactly as prescribed by your doctor. Do not take more or less Viokace than directed by your doctor.
What is Viokace?
Viokace is a prescription medicine used with a proton pump inhibitor medicine (PPI) to treat adults who cannot digest food normally. Adults with swelling of the pancreas that lasts a long time (chronic pancreatitis), or who have had some or all of their pancreas removed (pancreatectomy) may not digest food normally because they do not make enough enzymes or because their enzymes are not released into the bowel (intestine).
Viokace contains a mixture of digestive enzymes (including lipases, proteases, and amylases) from pig pancreas.
It is not known if Viokace is safe and effective in children. Use of...
